ZINZINO AB (PUBL): Share subscription due to warrants
7 augusti, 10:00
ZINZINO AB (PUBL): Share subscription due to warrants
In the option programme Zinzino's general meeting decided on 2020-05-15, 87,650 B shares have been subscribed. The price per share was SEK 45 and in total Zinzino's equity was raised by SEK 3,944,250.
In the option programme Zinzino's general meeting resolved on 31 May 2022, 13,300 B shares have been subscribed (series 2022/2027:1). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 744,800.
The total number of B shares increased by 100,950 to 31,170,664. The total number of shares after the increase was 36,252,567. The dilution amounted to 0.28 percent. Zinzino's share capital increased to SEK 3,625,256.70.
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge:
Certified Adviser:
DNB Carnegie Investment Bank AB (publ.)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, and Australia.
Ämnen i artikeln
ZINZINO AB (PUBL): Share subscription due to warrants
7 augusti, 10:00
ZINZINO AB (PUBL): Share subscription due to warrants
In the option programme Zinzino's general meeting decided on 2020-05-15, 87,650 B shares have been subscribed. The price per share was SEK 45 and in total Zinzino's equity was raised by SEK 3,944,250.
In the option programme Zinzino's general meeting resolved on 31 May 2022, 13,300 B shares have been subscribed (series 2022/2027:1). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 744,800.
The total number of B shares increased by 100,950 to 31,170,664. The total number of shares after the increase was 36,252,567. The dilution amounted to 0.28 percent. Zinzino's share capital increased to SEK 3,625,256.70.
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge:
Certified Adviser:
DNB Carnegie Investment Bank AB (publ.)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, and Australia.
Ämnen i artikeln
Analys
Novo Nordisk
Bostadsmarknaden
Trumps handelskrig
Inflationen
.jpg&w=3840&q=75)
Fonder
Aktieråd
Analys
Novo Nordisk
Bostadsmarknaden
Trumps handelskrig
Inflationen
Fonder
Aktieråd
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
